( ro-Otology of the Army Research and Ref...)Need for Cost-effective Hearing Implants,Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
Need for Cost-effective Hearing Implants
ro-Otology of the Army Research and Referral Hospital here said: Les......Source-IANS...
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
ro-Otology of the Army Research and Referral Hospital here, said: "Less than 1,300 cochlear implant surgeries have been done in India so far and the Australian device was used in 1,000 cases."
Source-IANS
'"/>
Page:
1
2
Related medicine news :
1
.
Cost-effective antibiotics for sinusitis treatment
2
.
Cost-effective Meningitis Vaccine To Be Launched In Africa
3
.
Lowering Contrast Material Injection in Aged Patients is Cost-effective and can Offset Risks
4
.
Prevention (Of AIDS) By Circumcision More Cost-effective Than Cure
5
.
One-time Melanoma Screening Appears to Be Cost-effective for Elderly People
6
.
Hearing loss can be detected by simple screening
7
.
A High-Definition Hearing Aid that thinks for you
8
.
Vitamin E Could Restore Sudden Hearing Loss
9
.
Hearing loss can happen from regular exposure to carbon monoxide
10
.
Studies On Hearing Loss Discovers New Causes
11
.
Possibility Of Treatment For Permanent Hearing Loss
Post Your Comments:
*
Name:
*
Comment:
*
Email:
TAG:
Need
for
Cost
effective
Hearing
Implants
TAG:
Need
for
Cost
effective
Hearing
Implants
Breaking Medicine News(10 mins):
Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2
Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2
Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3
Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4
Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2
Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3
Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4
Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5
Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2
Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2
Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3
Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4
Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5
[
0
] Unanimous Vote Creates Largest RN Union in U.S. History
[
0
] Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765
[
0
] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans
[
1
] VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution
[
0
] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management
Other Medicine News:
Health News:Just in Time for the Holidays, The USO and CarePages.com Launch 'Operation: Show You Care' 2
Health News:Just in Time for the Holidays, The USO and CarePages.com Launch 'Operation: Show You Care' 3
Health News:A Better Smile Can Revive at Any Age 2
Health News:Vaccine shows promise in preventing mono 2
Health News:Silencing small but mighty cancer inhibitors 2
Health News:CSHL scientist recognized for accelerating cancer gene research 2
Health News:Is there a developmental component to the risk for depression? 2
Just in Time for the Holidays, The USO and CarePages.com Launch 'Operation: Show You Care'
A Better Smile Can Revive at Any Age
Vaccine shows promise in preventing mono
Silencing small but mighty cancer inhibitors
CSHL scientist recognized for accelerating cancer gene research
Is there a developmental component to the risk for depression?
Breaking Medicine Technology:
The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2
The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3
The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4
The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5
For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2
For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3
New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2
Troubled waters 3A Low Apalachicola River flow may hurt gulf fisheries 8930 1
Troubled waters 3A Low Apalachicola River flow may hurt gulf fisheries 8930 2
Troubled waters 3A Low Apalachicola River flow may hurt gulf fisheries 8930 3
Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 1
Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 2
Athletes spectators faced unprecedented air pollution at 2008 Olympic Games 8927 3
Scienceroll com on an iPhone Application for Cardiopulmonary Resuscitation Training 49493 1
[
0
] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
[
0
] For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain
[
1
] New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults
Other Medicine Technology:
PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2
PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3
PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Medicine Products:
Guilford-Wright Double Edge Knife
Schuknecht Roller Knife
Hough Fascia Knife
Paparella Incudostapedial Joint Knife
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health